Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the immunodiagnostics market grown in recent years?

Over the past few years, the size of the immunodiagnostics market has seen considerable growth. A leap from $22.88 billion in 2024 to $24.54 billion in 2025 is predicted, indicating a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the historical period include the rise in cases of infectious diseases, the escalation of autoimmune diseases, the diagnosis and observation of cancer, the global spread of infectious diseases, public health schemes, and screening programs.

How is the immunodiagnostics market size expected to evolve during the forecast period?

In the coming years, the immunodiagnostics market is projected to witness a robust enhancement in its size. It’s anticipated to expand to “$33.14 billion by 2029 at a compound annual growth rate (CAGR) of 7.8%. This expansion during the forecast timeframe can be linked to readiness and response to pandemics, the advancement of personalized medicine and biomarker discovery, the development of healthcare infrastructure in emerging markets, coordination with laboratory information systems, and the increasing prevalence of chronic diseases. Key trends projected for the forecast period encompass technologies related to multiplexing, point-of-care testing (POCT), biomarker discovery and personalized medicine, the emergence of digital immunodiagnostics, and a transition towards liquid biopsy.

Get your immunodiagnostics market report here!

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Which key drivers are propelling the immunodiagnostics market’s growth?

The escalating occurrence of communicable diseases is projected to accelerate the expansion of the immunodiagnostics market. These diseases are illnesses that can be spread among individuals, caused by various microbes such as viruses, bacteria, fungi, or parasites. A test known as an immunodiagnostic assay is employed to detect a virus in a blood sample. For example, in March 2024, as reported by the Centers for Disease Control and Prevention, a government agency in the US, there was a rise in tuberculosis cases, from 8,320 in 2022 to 9,615 in 2023. This increase correlates to an additional 1,295 cases. Consequently, the escalation in communicable diseases’ occurrence is projected to spur the growth of the immunodiagnostics market.

What are the market segments in the immunodiagnostics industry?

The immunodiagnostics market covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments, Software And Services

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Which leading companies are shaping the growth of the immunodiagnostics market?

Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

What key trends are currently impacting the immunodiagnostics market’s development?

In the immunodiagnostics industry, leading companies are centering their initiatives on creating novel solutions like the S. pneumoniae antigen immunodiagnostic assay. This cutting-edge diagnostic tool detects the presence of Streptococcus pneumoniae antigens, which aids in the diagnosis of pneumococcal infections. For instance, the Italy-based biotechnology firm, DiaSorin S.p.A., introduced the LIAISON S. pneumoniae antigen immunodiagnostic assay in September 2024. This test is specifically designed for qualitatively identifying Streptococcus pneumoniae antigens in the urine samples of adults suspected to have pneumococcal pneumonia. The assay’s high capacity for processing number of tests in short span and ability to deliver results in a mere 35 minutes enable healthcare professionals to diagnose pneumococcal pneumonia swiftly, distinguishing it from other respiratory infections. The test, operated on LIAISON CLIA analyzers, supports fast and precise antimicrobial treatment. Additionally, its capability to recognize 91 serotypes bolsters clinical decision-making and encourages efficient antibiotic stewardship. This represents a notable advancement in the immunodiagnostics sector for community-acquired pneumonia.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10093

Which geographic areas are influencing the growth of the immunodiagnostics market?

North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Autoimmune Disease Diagnosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Orphan Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Immunity Boosting Food Products Global Market Opportunities And Strategies To 2033

https://www.thebusinessresearchcompany.com/report/immunity-boosting-food-products-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: